BLK
BlackRock, Inc.
BLK has the edge over NEWT overall, supported by stronger fundamentals and lower modeled downside.
NEWT
NewtekOne, Inc.
NEWT offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
NEWT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
NEWT's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NEWT.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
NEWT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 5.2x | $10.44 | — |
| Cheap | 5.5x | $10.25 | -1.8% |
| Current | 5.6x | $10.44 | — |
| Fair | 7.1x | $13.41 | +28% |
| Expensive | 10x | $19.07 | +83% |
Historical ranges are pointers, not guarantees.
NEWT has the edge over BLK in the historical PE scenario, which offers more potential upside but is not a forecast.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
NEWT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NEWT's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK earned $43.87 per share over the past year, up 11% from the year before.
NEWT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.02 | +7.3% |
| Q3 2026 | $1.88 | -16% |
| Q2 2026 | $2.21 | +9.4% |
| Q1 2026 | $2.26 | +17% |
| Q4 2025 | $2.18 | +11% |
| Q3 2025 | $2.24 | +32% |
| Q2 2025 | $2.02 | +24% |
| Q1 2025 | $1.93 | +32% |
| Q4 2024 | $1.96 | +27% |
NEWT has the edge over BLK on earnings, with more consistent year-over-year improvement.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over NEWT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
NEWT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.8M | -4.2% |
| Q2 2026 | $75.1M | +7% |
| Q1 2026 | $71M | +7% |
| Q4 2025 | $73.3M | -2.7% |
| Q3 2025 | $74.9M | +19% |
| Q2 2025 | $70.2M | +15% |
| Q1 2025 | $66.3M | +14% |
| Q4 2024 | $75.4M | +42% |
NEWT's revenue has held roughly level: $72M last quarter, down 4.2% from the same quarter a year ago.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over NEWT on cash generation, producing positive trailing cash flow while its opponent burns cash.
NEWT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$152.4M | +$14.9M |
| Q2 2026 | -$163.3M | +$36.6M |
| Q1 2026 | -$257.5M | -$196.8M |
| Q4 2025 | -$151.4M | -$59.8M |
| Q3 2025 | -$167.3M | -$141.4M |
| Q2 2025 | -$199.9M | -7108% |
| Q1 2025 | -$60.7M | -$22M |
| Q4 2024 | -$91.7M | -$39M |
NEWT's free cash flow was −$725M over the past year, against −$520M the year before. Free cash flow isn't a meaningful measure for financial services companies like NEWT.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over NEWT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
NEWT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +51K shares |
| 1 year | +10% | +2.7M shares |
| 3 years | +16% | +4M shares |
NEWT has 29M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $167,000 |
| Q3 2025 | — |
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
NEWT Net Leverage
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
NEWT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 2.7 | Oversold |
NEWT's weekly RSI is 36 (neutral) and its Stochastic is 3 (oversold).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
NEWT PE vs Financial Services Sector
| Metric | NEWT | Sector median | Relative |
|---|---|---|---|
| PE | 5.6x | 13x | 57% below |
| PE % | 19 | 63 | 44 pts below |
NEWT has the edge over BLK on valuation relative to its sector.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK has the edge over NEWT on trend strength, trading above more of its moving averages.
NEWT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.0 | 4.7% below |
| 20 week MA | $12.4 | 16% below |
| 50 week MA | $12.6 | 17% below |
| 100 week MA | $12.1 | 14% below |
| 200 week MA | $13.0 | 19% below |
NEWT is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has the edge over NEWT on returns for 2026, with the stronger performance.
NEWT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $18.2 | -20% |
| 2021 | $18.2 | $27.9 | +54% |
| 2022 | $27.9 | $16.7 | -40% |
| 2023 | $16.7 | $13.8 | -17% |
| 2024 | $13.8 | $13.0 | -5.7% |
| 2025 | $13.0 | $11.5 | -12% |
| 2026 YTD | $11.5 | $10.4 | -9.1% |
NEWT has finished four years in a row lower, and it's down 9.1% so far in 2026.